Disease/Infection News

RSS

Dizziness is a common symptom of COVID-19

New research published in Internal and Emergency Medicine discusses the relationship between SARS-CoV-2 infection and dizziness.

6 Feb 2022

COVID-19 severity does not differ by trimester, study says

Research shows that pregnant people who contract COVID-19 are at increased risk of severe complications, including hospitalization, ventilation, and death, compared to pregnant people without COVID-19.

4 Feb 2022

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Within only three weeks after the omicron variant was first identified among Houston Methodist patients, this variant rapidly took over and became the cause of a majority of new cases.

4 Feb 2022

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H. Chan School of Public Health.

4 Feb 2022

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Researchers from Yale University, University of Basel, University of Antwerp, CDDEP and other institutions recently published 'Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modeling study' in The Lancet Infectious Diseases.

4 Feb 2022

mRNA booster vaccination shown to induce robust neutralizing antibodies against SARS-CoV-2 omicron variant

Scientists recently assessed the immunogenicity of a third booster dose of COVID-19 vaccines against SARS-CoV-2 variants.

4 Feb 2022

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.

4 Feb 2022

Understanding how COVID-19 infection spreads from the upper airways to the lungs

Whether COVID-19 becomes a life-threatening disease depends, in part, on the virus reaching one's lungs. Scientists suspect the initial infected tissues in the upper airway can act as the source for virus-laden droplets or boluses, that are aspirated into the lungs.

4 Feb 2022

Observational analysis of nucleocapsid and spike antibody responses post-SARS-CoV-2 infection

Scientists aimed at furthering our understanding of anti-Nucleocapsid and anti-Spike responses over time.

4 Feb 2022

The effect of SARS-CoV-2 infection on pregnant mothers, the placenta, and infants

A group of scientists focussed on assessing if SARS-CoV-2 infection causes any particular histologic change in the placenta.

4 Feb 2022

Memory B cells found to potently neutralize SARS-CoV-2 Omicron variant

A team of researchers recently captured memory B cells from a cohort of SARS-CoV-2 convalescent or mRNA-vaccinated individuals to study the evolution of B cell-mediated antibody responses to the N-terminal domain in humans.

4 Feb 2022

Study finds the vaccine effectiveness of 3 COVID-19 vaccines to be lower than earlier estimates

The researchers studied residents in Aragon, Spain, and conducted a prospective population-based cohort study among the Aragon Health Service users of 16 years old and higher.

4 Feb 2022

Exploring the comparative efficacy of booster vaccines against SARS-CoV-2 Omicron and Delta variants

In a new study, researchers assessed the effectiveness of SARS-CoV-2 Omicron and Delta variants.

4 Feb 2022

Hp-XeMRI identifies impaired gas transfer in lungs of non-hospitalised breathless Long-COVID patients with normal CT scans

Researchers have been investigating the symptoms and effect on the lungs in those who suffered from hospitalization due to COVID-19 but fully recovered and non-hospitalized sufferers of long-COVID.

4 Feb 2022

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

In a new study, a team of researchers developed a hybrid vaccine for SARS-CoV-2 and influenza viruses using influenza virus-like particles (VLP).

4 Feb 2022

Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

In a new study, researchers comprehensively investigated a public-facing office in England where a SARS-CoV-2 outbreak occurred during August-September 2021 to identify workplace and worker-related risk factors.

4 Feb 2022

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

In a new study, researchers showed that 425 nm blue light can inactivate all major SARS CoV 2 variants.

4 Feb 2022

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

In a new study, a team of researchers assessed the affinity of the SARS-CoV-2 Omicron variant of concern towards major histocompatibility complex (MHC) binding

4 Feb 2022

Do COVID-19 vaccinations increase the length of the menstrual cycle?

In this interview, we speak to Professor Alison Edelman about her latest research that investigated the effects COVID-19 vaccinations have on the menstrual cycle.

4 Feb 2022

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

A recent study from Spain showed that the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can change the overall structure and diversity of the nasopharyngeal microbiota in pregnant women – which persists even weeks after clinical infection. The paper is currently available on Research Square preprint* server.

3 Feb 2022

Disease/Infection News

Dizziness is a common symptom of COVID-19

COVID-19 severity does not differ by trimester, study says

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

mRNA booster vaccination shown to induce robust neutralizing antibodies against SARS-CoV-2 omicron variant

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Understanding how COVID-19 infection spreads from the upper airways to the lungs

Observational analysis of nucleocapsid and spike antibody responses post-SARS-CoV-2 infection

The effect of SARS-CoV-2 infection on pregnant mothers, the placenta, and infants

Memory B cells found to potently neutralize SARS-CoV-2 Omicron variant

Study finds the vaccine effectiveness of 3 COVID-19 vaccines to be lower than earlier estimates

Exploring the comparative efficacy of booster vaccines against SARS-CoV-2 Omicron and Delta variants

Hp-XeMRI identifies impaired gas transfer in lungs of non-hospitalised breathless Long-COVID patients with normal CT scans

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Do COVID-19 vaccinations increase the length of the menstrual cycle?

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News